Literature DB >> 18457681

Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC).

Chris E Cooper1, Radu Silaghi-Dumitrescu, Martine Rukengwa, Abdu I Alayash, Paul W Buehler.   

Abstract

Acellular hemoglobins developed as oxygen bridging agents with volume expanding properties ("blood substitutes") are prone to autoxidation and oxidant-mediated structural changes in circulation. In the presence of hydrogen peroxide and either ascorbate or urate we show that ferric hemoglobin functions as a true enzymatic peroxidase. The activity saturates with both substrates and is linearly dependent on protein concentration. The activity is enhanced at low pH with a pKa of 4.7, consistent with protonation of the ferryl species (Fe(IV)-OH) as the active intermediate. To test whether these redox reactions define its behaviour in vivo we exchanged transfused guinea pigs with 50% polymerized bovine Hb (PolyHbBv) and monitored plasma levels of endogenous ascorbate and urate. Immediately after transfusion, met PolyHbBv levels increased up to 30% of total Hb and remained at this level during the first 24 h post transfusion. Plasma ascorbate decreased by 50% whereas urate levels remained unchanged after transfusion. A simple kinetic model, assuming that ascorbate was a more active ferric heme reductase and peroxidase substrate than urate, was consistent with the in vivo data. The present finding confirms the primary and secondary roles of ascorbate and urate respectively in maintaining the oxidative stability of infused Hb.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18457681     DOI: 10.1016/j.bbapap.2008.03.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Towards the development of hemerythrin-based blood substitutes.

Authors:  Augustin C Mot; Alina Roman; Iulia Lupan; Donald M Kurtz; Radu Silaghi-Dumitrescu
Journal:  Protein J       Date:  2010-08       Impact factor: 2.371

2.  Ascorbate protects the diheme enzyme, MauG, against self-inflicted oxidative damage by an unusual antioxidant mechanism.

Authors:  Zhongxin Ma; Victor L Davidson
Journal:  Biochem J       Date:  2017-07-17       Impact factor: 3.857

3.  Bacteria capture iron from heme by keeping tetrapyrrol skeleton intact.

Authors:  Sylvie Létoffé; Gesine Heuck; Philippe Delepelaire; Norbert Lange; Cécile Wandersman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

Review 4.  Examining and mitigating acellular hemoglobin vasoactivity.

Authors:  Pedro Cabrales
Journal:  Antioxid Redox Signal       Date:  2012-10-11       Impact factor: 8.401

5.  Towards hemerythrin-based blood substitutes: comparative performance to hemoglobin on human leukocytes and umbilical vein endothelial cells.

Authors:  Eva Fischer-Fodor; Augustin Mot; Florina Deac; Mariann Arkosi; Radu Silaghi-Dumitrescu
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

6.  Amplification of antioxidant activity of haptoglobin(2-2)-hemoglobin at pathologic temperature and presence of antibiotics.

Authors:  Masoumeh Tayari; Danial Afsharzadeh
Journal:  Indian J Clin Biochem       Date:  2011-12-25

7.  A new polyethyleneglycol-derivatized hemoglobin derivative with decreased oxygen affinity and limited toxicity.

Authors:  Oana Zolog; Augustin Mot; Florina Deac; Alina Roman; Eva Fischer-Fodor; Radu Silaghi-Dumitrescu
Journal:  Protein J       Date:  2011-01       Impact factor: 2.371

Review 8.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

Review 9.  Oxidative pathways in the sickle cell and beyond.

Authors:  Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2017-05-20       Impact factor: 3.039

10.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.